Adjuvant fractionated high-dose-rate int
β
Jiade J. Lu; Thomas P. Shakespeare; Luke Kim Siang Tan; Boon Cher Goh; Jay S. Co
π
Article
π
2004
π
John Wiley and Sons
π
English
β 120 KB
## Abstract ## Background. The value of highβdoseβrate intracavitary brachytherapy (HDRIB) for persistent or recurrent nasopharyngeal carcinoma has been well described; however, the benefit of routine adjuvant fractionated HDRIB following external beam radiation therapy (EBRT) has not been complet